Lili Zhou1, Camron D Bryant2, Andrew Loudon3, Abraham A Palmer4, Martha Hotz Vitaterna1, Fred W Turek1. 1. Center for Sleep and Circadian Biology, Northwestern University, Evanston, IL ; Department of Neurobiology, Northwestern University, Evanston, IL. 2. Departments of Pharmacology and Experimental Therapeutics and Psychiatry, Boston University School of Medicine, Boston, MA. 3. Faculty of Life Sciences, University of Manchester, Manchester, UK. 4. Department of Human Genetics, University of Chicago, Chicago, IL ; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL.
Abstract
STUDY OBJECTIVES: Efforts to identify the genetic basis of mammalian sleep have included quantitative trait locus (QTL) mapping and gene targeting of known core circadian clock genes. We combined three different genetic approaches to identify and test a positional candidate sleep gene - the circadian gene casein kinase 1 epsilon (Csnk1e), which is located in a QTL we identified for rapid eye movement (REM) sleep on chromosome 15. MEASUREMENTS AND RESULTS: Using electroencephalographic (EEG) and electromyographic (EMG) recordings, baseline sleep was examined in a 12-h light:12-h dark (LD 12:12) cycle in mice of seven genotypes, including Csnk1e(tau/tau) and Csnk1e(-/-) mutant mice, Csnk1e (B6.D2) and Csnk1e (D2.B6) congenic mice, and their respective wild-type littermate control mice. Additionally, Csnk1e(tau/tau) and wild-type mice were examined in constant darkness (DD). Csnk1e(tau/tau) mutant mice and both Csnk1e (B6.D2) and Csnk1e (D2.B6) congenic mice showed significantly higher proportion of sleep time spent in REM sleep during the dark period than wild-type controls - the original phenotype for which the QTL on chromosome 15 was identified. This phenotype persisted in Csnk1e(tau/tau) mice while under free-running DD conditions. Other sleep phenotypes observed in Csnk1e(tau/tau) mice and congenics included a decreased number of bouts of nonrapid eye movement (NREM) sleep and an increased average NREM sleep bout duration. CONCLUSIONS: These results demonstrate a role for Csnk1e in regulating not only the timing of sleep, but also the REM sleep amount and NREM sleep architecture, and support Csnk1e as a causal gene in the sleep QTL on chromosome 15.
STUDY OBJECTIVES: Efforts to identify the genetic basis of mammalian sleep have included quantitative trait locus (QTL) mapping and gene targeting of known core circadian clock genes. We combined three different genetic approaches to identify and test a positional candidate sleep gene - the circadian gene casein kinase 1 epsilon (Csnk1e), which is located in a QTL we identified for rapid eye movement (REM) sleep on chromosome 15. MEASUREMENTS AND RESULTS: Using electroencephalographic (EEG) and electromyographic (EMG) recordings, baseline sleep was examined in a 12-h light:12-h dark (LD 12:12) cycle in mice of seven genotypes, including Csnk1e(tau/tau) and Csnk1e(-/-) mutant mice, Csnk1e (B6.D2) and Csnk1e (D2.B6) congenic mice, and their respective wild-type littermate control mice. Additionally, Csnk1e(tau/tau) and wild-type mice were examined in constant darkness (DD). Csnk1e(tau/tau) mutant mice and both Csnk1e (B6.D2) and Csnk1e (D2.B6) congenic mice showed significantly higher proportion of sleep time spent in REM sleep during the dark period than wild-type controls - the original phenotype for which the QTL on chromosome 15 was identified. This phenotype persisted in Csnk1e(tau/tau) mice while under free-running DD conditions. Other sleep phenotypes observed in Csnk1e(tau/tau) mice and congenics included a decreased number of bouts of nonrapid eye movement (NREM) sleep and an increased average NREM sleep bout duration. CONCLUSIONS: These results demonstrate a role for Csnk1e in regulating not only the timing of sleep, but also the REM sleep amount and NREM sleep architecture, and support Csnk1e as a causal gene in the sleep QTL on chromosome 15.
Authors: Jean-Pierre Etchegaray; Elizabeth A Yu; Premananda Indic; Robert Dallmann; David R Weaver Journal: PLoS One Date: 2010-04-22 Impact factor: 3.240
Authors: Priyattam J Shiromani; Man Xu; Elizabeth M Winston; Samara N Shiromani; Dmitry Gerashchenko; David R Weaver Journal: Am J Physiol Regul Integr Comp Physiol Date: 2004-03-18 Impact factor: 3.619
Authors: P L Lowrey; K Shimomura; M P Antoch; S Yamazaki; P D Zemenides; M R Ralph; M Menaker; J S Takahashi Journal: Science Date: 2000-04-21 Impact factor: 47.728
Authors: V M Philip; S Duvvuru; B Gomero; T A Ansah; C D Blaha; M N Cook; K M Hamre; W R Lariviere; D B Matthews; G Mittleman; D Goldowitz; E J Chesler Journal: Genes Brain Behav Date: 2009-09-22 Impact factor: 3.449
Authors: Christopher J Winrow; Deanna L Williams; Andrew Kasarskis; Joshua Millstein; Aaron D Laposky; He S Yang; Karrie Mrazek; Lili Zhou; Joseph R Owens; Daniel Radzicki; Fabian Preuss; Eric E Schadt; Kazuhiro Shimomura; Martha H Vitaterna; Chunsheng Zhang; Kenneth S Koblan; John J Renger; Fred W Turek Journal: PLoS One Date: 2009-04-10 Impact factor: 3.240
Authors: Jonathan P Wisor; Bruce F O'Hara; Akira Terao; Chris P Selby; Thomas S Kilduff; Aziz Sancar; Dale M Edgar; Paul Franken Journal: BMC Neurosci Date: 2002-12-20 Impact factor: 3.288
Authors: E E Young; C D Bryant; S E Lee; X Peng; B Cook; H K Nair; K J Dreher; X Zhang; A A Palmer; J M Chung; J S Mogil; E J Chesler; W R Lariviere Journal: Genes Brain Behav Date: 2016-07 Impact factor: 3.449
Authors: Jennifer A Ritonja; Kristan J Aronson; Lisa Flaten; Danai G Topouza; Qing Ling Duan; Francine Durocher; Joan E Tranmer; Parveen Bhatti Journal: Epigenetics Date: 2021-11-26 Impact factor: 4.861